Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022
SAN CARLOS, Calif., Sept. 05, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
Londian Wason Signs Cooperation Agreement in Kazakhstan to Jointly Build a High-Performance Electrolytic Copper Foil Production Base with NAIKAN Ltd.
From Robot Companions to Robot Cafe: Star Plus Legend Reimagines Consumer Experiences Through IP+Physical AI
Hong Kong International Wine & Spirits Fair attracts over 8,200 buyers with enthusiastic participation on Public Day
Six dirhams a gate. The real 2026 cost of a Dubai commute and three ways out
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community